Form 8-K - Current report:
SEC Accession No. 0001213900-24-076515
Filing Date
2024-09-06
Accepted
2024-09-06 16:10:12
Documents
22
Period of Report
2024-09-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0213757-8k_60degrees.htm   iXBRL 8-K 56530
2 FORM OF SECURITIES PURCHASE AGREEMENT ea021375701ex10-1_60degrees.htm EX-10.1 255339
3 FORM OF REGISTRATION RIGHTS AGREEMENT ea021375701ex10-2_60degrees.htm EX-10.2 142230
4 FORM OF PRE-FUNDED WARRANT ea021375701ex10-3_60degrees.htm EX-10.3 93021
5 FORM OF SERIES A WARRANTS ea021375701ex10-4_60degrees.htm EX-10.4 93711
6 FORM OF SERIES B WARRANTS ea021375701ex10-5_60degrees.htm EX-10.5 94337
7 FORM OF PLACEMENT AGENT WARRANT ea021375701ex10-6_60degrees.htm EX-10.6 96006
8 PRESS RELEASE DATED SEPTEMBER 4, 2024 ea021375701ex99-1_60degrees.htm EX-99.1 11752
9 PRESS RELEASE DATED SEPTEMBER 6, 2024 ea021375701ex99-2_60degrees.htm EX-99.2 11653
  Complete submission text file 0001213900-24-076515.txt   1288211

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE sxtp-20240904.xsd EX-101.SCH 3813
11 XBRL DEFINITION FILE sxtp-20240904_def.xml EX-101.DEF 26668
12 XBRL LABEL FILE sxtp-20240904_lab.xml EX-101.LAB 36762
13 XBRL PRESENTATION FILE sxtp-20240904_pre.xml EX-101.PRE 25292
25 EXTRACTED XBRL INSTANCE DOCUMENT ea0213757-8k_60degrees_htm.xml XML 5916
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 241284594
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)